Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

NCT07429461 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Acute Lymphoblastic Leukemia

Interventions

DRUG: SYNCAR-100 Injection

Sponsor

Zhejiang University

Collaborators

[object Object]